Skip to main navigation
  • Investors
Alnylam

SEC Filing Details

Document Details

Form
DEF 14A
Filing Date
Mar 24, 2025
Document Date
May 8, 2025
Form Description
Official notification to shareholders of matters to be brought to a vote ("Proxy")
Filing Group
Proxy Filings
Company
Alnylam Pharmaceuticals, Inc.
Issuer
ALNYLAM PHARMACEUTICALS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
XML - XBRL INSTANCE DOCUMENT

Recent Press Releases

View all releases  RSS

  • May 19,2026
    Summary ToggleAlnylam Issues 2025 Corporate Responsibility Report
  • May 12,2026
    Summary ToggleNew Data Analyses Presented at Heart Failure 2026 Demonstrate Robust and Consistent Clinical Benefit of Vutrisiran as a First-Line Treatment Option Across ATTR-CM Patient Populations, Including Patients with a High Disease Burden
  • May 07,2026
    Summary ToggleAlnylam to Webcast Presentations at Upcoming Investor Conferences
View all releases

: (Common):

Price:
Change (%):
Volume:
Data as of
Copyright Refinitiv. Minimum 15 minutes delay
Learn More
  • X
  • linkedin
  • youtube

Copyright © 2026 Alnylam Pharmaceuticals, Inc.   ---   All Rights Reserved   ---   Media Kit   |   Legal Notice   |   Privacy Policy   |   Site Map